RNA Therapeutics
Part of Healthcare - Genomics & Precision Medicine
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 ALNY | Alnylam Pharmaceuticals, Inc. | $40.3b | $303.03 | -0.2% | 1.0M |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | $12.6b | $74.49 | -0.9% | 2.0M |
 ARWR | Arrowhead Research Corporation | $11.0b | $73.09 | -2.8% | 1.2M |
 WVE | Wave Life Sciences Ltd. Ordinary Shares | $1.3b | $5.74 | -5.8% | 4.0M |
 CAMP | CAMP4 Therapeutics Corporation Common Stock | $228.0m | $4.07 | -5.3% | 69.0K |
 RNA | Atrium Therapeutics, Inc. Common Stock | $222.4m | $11.80 | -4.1% | 209.5K |
 RNAC | Cartesian Therapeutics, Inc. Common Stock | $221.5m | $5.81 | -11.3% | 278.8K |
 PRQR | ProQR Therapeutics N.V. Ordinary Shares | $166.5m | $1.50 | -1.6% | 449.7K |
 XCUR | Exicure, Inc. Common Stock | $20.3m | $3.00 | +1.4% | 17.3K |
 PHIO | Phio Pharmaceuticals Corp. Common Stock | $12.9m | $1.05 | -7.9% | 126.4K |